SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-012428
Filing Date
2020-08-11
Accepted
2020-08-11 16:00:53
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crdf-20200630.htm   iXBRL 10-Q 1779899
2 EX-31.1 crdf-063020exhibit311.htm EX-31.1 12661
3 EX-31.2 crdf-063020exhibit312.htm EX-31.2 12631
4 EX-32.1 crdf-063020exhibit321.htm EX-32.1 7609
5 EX-32.2 crdf-063020exhibit322.htm EX-32.2 7567
  Complete submission text file 0001628280-20-012428.txt   7302351

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20200630.xsd EX-101.SCH 44211
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crdf-20200630_cal.xml EX-101.CAL 77580
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20200630_def.xml EX-101.DEF 261818
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20200630_lab.xml EX-101.LAB 555806
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20200630_pre.xml EX-101.PRE 371491
11 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20200630_htm.xml XML 1321598
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 201092375
SIC: 2836 Biological Products, (No Diagnostic Substances)